The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 115.00
Bid: 114.50
Ask: 121.50
Change: 1.00 (0.88%)
Spread: 7.00 (6.114%)
Open: 114.00
High: 118.00
Low: 114.00
Prev. Close: 114.00
XAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options and Deferred Bonus Share Awards

7 Apr 2022 14:50

RNS Number : 6909H
Xaar PLC
07 April 2022
 

Xaar plc

Grant of Options and Deferred Bonus Share Awards

Grant of Options

Xaar plc (the "Company") announces that on 6 April 2022 the persons discharging managerial responsibilities of the Company were granted the following nil priced share options over ordinary shares of 10 pence each in the Company ("Ordinary Shares") under the terms of the Xaar 2017 Long Term Incentive Plan ("LTIP"):

Name

No. of options* granted over Ordinary Shares

Total no. of options** held post grant

John Mills

207,932

1,087,225

Ian Tichias

92,414

477,784

Graham Tweedale

59,299

240,007

 

* Options granted on 6 April 2022 under the LTIP scheme.

** Options granted under all schemes, including the deferred bonus shares detailed below.

This grant was approved by the Remuneration Committee on 6 April 2022.

No consideration was paid for the grant of any of the options, or is due on the exercise of options granted under the LTIP scheme. These options carry the performance criteria of EPS and TSR (60%/40% weighting respectively) which must be achieved during a 3 year vesting period. Actual performance targets are considered commercially sensitive and will be disclosed retrospectively.

The options vest on the dealing day following the announcement by the Company of its annual results for 2024 or, if later, the date on which the Remuneration Committee determines whether the performance condition and any other condition has been satisfied (in whole or in part), and for the Executive Directors these are exercisable 2 years after this date (for the other persons discharging managerial responsibilities, these are exercisable on vesting). The options will expire on the tenth anniversary of the date of grant.

 

Deferred Bonus Share Awards

The Company announces that on 6 April 2022 the Executive Directors of the Company were granted the following nil-cost share options over ordinary shares of 10 pence each in the Company ("Ordinary Shares") under the terms of the Xaar 2020 Deferred Bonus Plan (the "Plan"):

Name

No. of deferred bonus share awards granted over Ordinary Shares

John Mills

11,944

Ian Tichias

6,689

 

This grant was approved by the Remuneration Committee on 6 April 2022.

The nil-cost options reflect the deferred portion of the bonuses earned for the year ended 31 December 2021, subject to continued employment, and will, ordinarily, vest on the dealing day following the announcement by the Company of its annual results for 2023.

 

The FCA notification, made in accordance with the requirements of the UK Market Abuse Regulation is appended below and gives further details on the transactions described above. 

This notification is made in accordance with DTR 3.1.4 R(1).

 

 

Enquiries:

Xaar plc

+44 (0)1223 423 663

Camila Cottage, Company Secretary

investor.relations@xaar.com

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. John Mills

2. Ian Tichias

3. Graham Tweedale

2

Reason for the notification

a)

Position/status

1. Chief Executive Officer

2. Chief Financial Officer

3. Chief Operations Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Xaar plc

b)

LEI

213800MXEC3KAOBBPO57

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

GB0001570810

b)

Nature of the transaction

Grant of Options under the Xaar plc 2017 Long Term Incentive Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1. £nil

1. 207,932

2. £nil

2. 92,414

3. £nil

3. 59,299

d)

Aggregated information

- Aggregated volume

1. 207,932

2. 92,414

3. 59,299

- Price

1. £nil

2. £nil

3. £nil

e)

Date of the transaction

1. 6 April 2022

2. 6 April 2022

3. 6 April 2022

f)

Place of the transaction

Outside a trading venue

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. John Mills

2. Ian Tichias

2

Reason for the notification

a)

Position/status

1. Chief Executive Officer

2. Chief Financial Officer

 

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Xaar plc

b)

LEI

213800MXEC3KAOBBPO57

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

GB0001570810

b)

Nature of the transaction

Grant of options under the Xaar 2020 Deferred Bonus Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1. £nil

1. 11,944

2. £nil

2. 6,689

d)

Aggregated information

- Aggregated volume

1. 11,944

2. 6,689

- Price

1. £nil

2. £nil

e)

Date of the transaction

1. 6 April 2022

2. 6 April 2022

 

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBXGDSCSGDGDR
Date   Source Headline
1st May 20244:15 pmRNSTotal Voting Rights
30th Apr 20244:30 pmRNSDirector/PDMR Shareholding
22nd Apr 202410:51 amRNSAnnual Financial Report
2nd Apr 202412:00 pmRNSTotal Voting Rights
1st Mar 202410:15 amRNSTotal Voting Rights
26th Feb 20249:00 amRNSHolding(s) in Company
23rd Feb 202410:30 amRNSBoard Change
1st Feb 20241:32 pmRNSTotal Voting Rights
29th Jan 202412:04 pmRNSHolding(s) in Company
12th Jan 20243:15 pmRNSBlock listing Interim Review
12th Jan 20247:00 amRNSNotification of Results & Full year Guidance
8th Jan 202412:36 pmRNSTotal Voting Rights
12th Dec 20239:00 amRNSNotification of Transactions of Directors & PDMRs
11th Dec 20233:00 pmRNSNotification of Transactions of Directors & PDMRs
1st Dec 202311:00 amRNSTotal Voting Rights
1st Dec 202310:00 amRNSDirector Declaration
29th Nov 20237:00 amRNSTrading Update
17th Nov 20234:07 pmRNSHolding(s) in Company
9th Nov 20231:53 pmRNSDirector/PDMR Shareholding
3rd Nov 202310:52 amRNSHolding(s) in Company
1st Nov 20234:03 pmRNSTotal Voting Rights
30th Oct 20237:00 amRNSBoard Changes
2nd Oct 202311:45 amRNSTotal Voting Rights
21st Sep 20233:16 pmRNSHolding(s) in Company
21st Sep 20239:57 amRNSHolding(s) in Company
19th Sep 20237:00 amRNS2023 Interim Results
11th Sep 20232:11 pmRNSHolding(s) in Company
11th Sep 202312:14 pmRNSHolding(s) in Company
11th Sep 202312:07 pmRNSHolding(s) in Company
11th Sep 202312:03 pmRNSHolding(s) in Company
11th Sep 202312:02 pmRNSHolding(s) in Company
11th Sep 202312:02 pmRNSHolding(s) in Company
7th Sep 20239:00 amRNSNotice of 2023 Half Year Results
1st Sep 20239:30 amRNSTotal Voting Rights
25th Aug 202312:13 pmRNSHolding(s) in Company
23rd Aug 202310:24 amRNSHolding(s) in Company
18th Aug 202310:30 amRNSChange of Auditor
17th Aug 202312:55 pmRNSHolding(s) in Company
3rd Aug 20237:00 amRNSTrading Update
1st Aug 20232:00 pmRNSTotal Voting Rights
28th Jul 20234:30 pmRNSHolding(s) in Company
5th Jul 20239:00 amRNSXaar plc - Commercial partnership with Quantica
4th Jul 20233:00 pmRNSBlock listing Interim Review
3rd Jul 20232:53 pmRNSTotal Voting Rights
1st Jun 202310:37 amRNSTotal Voting Rights
31st May 202311:30 amRNSResult of AGM
31st May 20239:00 amRNSBoard Changes
11th May 20235:41 pmRNSHolding(s) in Company
10th May 20233:10 pmRNSDirector/PDMR Shareholding
2nd May 202312:39 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.